NEWS
News Articles
WHO Formally Authorizes the Use of the AstraZeneca Vaccine.
The World Health Organization on Monday authorized the use of the AstraZeneca-Oxford vaccine, clearing a path for the cheap and easy-to-store shots to be distributed in lower- and middle-income countries around the world. A small clinical trial in South Africa recently failed to show that the vaccine could keep people from getting mild or moderate…
Read MoreSymptomatic Covid-19 Cases Dropped 94% With Pfizer Vaccine, Israeli Data Show
Study comparing two groups of 600,000 people also found vaccine recipients 92% less likely to develop severe illness TEL AVIV—The latest data from Israel shows a 94% drop in symptomatic Covid-19 infections among 600,000 people who received two doses of Pfizer Inc. and BioNTech SE’s vaccine, offering important new insights for other countries as they roll out their own campaigns. The vaccinated…
Read MoreAtlanta digital health company Sharecare to go public in SPAC deal
Sharecare, an Atlanta-based digital health management platform, is going public through a merger with a special purpose acquisition company, or SPAC, according to a Feb. 12 announcement. After merging with Falcon Capital Acquisition Corp. (NASDAQ: FCAC), Sharecare will become Sharecare Inc. and be listed under the ticket symbol SHCR. The deal is set to close in the second quarter and would put…
Read MoreBD begins U.S., European rollout of new test for the flu, COVID-19 and its new strains
BD has secured U.S. and European authorizations for a new COVID-19 test that screens for the coronavirus as well as influenza A and B—and the company said it’s shown to work against the emerging variants first identified in the U.K. and South Africa. The molecular laboratory test is designed to turn around results in two…
Read MoreBiden says U.S. will have enough vaccine for 300 million people by end of July
The administration used options in existing contracts to purchase another 200 million doses, increasing supply by 50 percent President Biden said Thursday that his administration had finalized deals for another 200 million doses of the two coronavirus vaccines authorized in the United States, giving the country enough vaccine by the end of July to cover every American…
Read MoreGeoVax Announces Pricing of $9.0 Million Bought Deal Offering
ATLANTA, GA, February 8, 2021 – GeoVax Labs, Inc. (Nasdaq: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced that it has entered into an underwriting agreement with Maxim Group LLC under which the underwriter has agreed to purchase, on a firm commitment basis, 1,440,000 shares…
Read More